Vertical alliance networks: The case of university–biotechnology–pharmaceutical alliance chains

Stuart, Toby E.; Ozdemir, Salih Zeki; Ding, Waverly W.

doi:10.1016/j.respol.2007.02.016

Cited by 239 publications

(187 citation statements)

References 59 publications

Supporting

Mentioning

162

Contrasting

Unclassified

Order By: Relevance

“…Biotech SMEs maintain broad and deep interaction with universities because these interactions increase a firm's stock of knowledge [16]. Zucker et al investigated co-authorships in the biotechnology industry and argued that new biotechnology firms have a strong dependence on university science research [10], [15], [22], [23].…”

Section: Resultsmentioning

confidence: 99%

“…Much of the previous studies on inter-firm collaboration implicitly locates biotech SMEs at the upstream pole of the established firms (for example, pharmaceutical or agricultural biotechnology) along industry value chains [10]- [12]. On the other hand, many biotech SMEs collaborate with universities or public research institutions in what are referred to as upstream partnerships [10], [13]- [16]. Therefore, biotech SMEs serve as "value-added intermediaries" between upstream partners (e.g.…”

Section: Hypothesismentioning

confidence: 99%

“…universities) and downstream partners (e.g. established enterprises), taking on "a dual role of knowledge transformation and commercialization" [1], [10]- [16]. Firms receiving venture capital are able to tap into their investors contacts, benefitting from a larger network of potential new customers (e.g.…”

Section: Hypothesismentioning

confidence: 99%

“…Firm size was controlled by using the log value of the number of employees [10], [17]. Age was calculated based on the foundation year and month of the firm [10]- [12], [16], [18]. Two indexes, POSIT_R and POSIT_D, have been Hypothesis 3: Venture capital financing is positively related to firms' innovation performance.…”

Section: B Definition Of Variablesmentioning

confidence: 99%

See 3 more Smart Citations

The Role of Venture Capital on Innovation in the Korean Biotechnology Industry

Sohn¹,

Kang²

2015

IJTEF

View full text Add to dashboard Cite

Abstract-Venture capital financing is generally considered as the most suitable external financing mode for New technology based SMEs, such as biotech SMEs. However, the way in which venture capital investments influence a firm's innovation performance is not as certain. In this paper, we empirically analyzed the impact of venture capital investments on networks and innovation performance in Korean biotech SMEs. Venture capital investment was positively associated with downstream partnerships, supporting Hypothesis 1-2 (β=0.29, p<0.001). Inter-firm collaborations were positively correlated with a firm's innovation performance, supporting Hypothesis 2 (β=0.18, p<0.10 in upstream partnerships, β=0.61, p<0.01 in downstream partnerships). This study showed the mechanism of venture capital investment influencing innovation by promoting downstream collaborations.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Hypothesismentioning

confidence: 99%

Section: Hypothesismentioning

confidence: 99%

Section: B Definition Of Variablesmentioning

confidence: 99%

See 2 more Smart Citations

The Role of Venture Capital on Innovation in the Korean Biotechnology Industry

Sohn¹,

Kang²

2015

IJTEF

View full text Add to dashboard Cite

show abstract

“…However the literature also describes a variety of vertical alliances where the owners of the needed assets -to whom the new firms technologies/products are particularly interesting (Rothaermel, 2002) -assume part or all the manufacturing and/or commercialisation activities Stuart et al, 2007). These alliances can be mutually favourable, even if often characterised by a degree of power asymmetry (Shan et al, 1994).…”

Section: Conditions For Entry Of Small Research-based Start-upsmentioning

confidence: 99%

The commercialisation of emerging energy technologies: the strategic alliances of high-technology entrepreneurial firms

Fontes¹,

Sousa

Pimenta³

2012

View full text Add to dashboard Cite

Influence of network ties on inter‐firm network management activities. A comparative study between international new ventures and international mature firms

Ripollés

Blesa

2017

Can J Adm Sci

View full text Add to dashboard Cite

This article investigates the types of network ties that contribute to the development of inter‐firm network management activities. It also examines whether these activities improve performance in the firms involved in those relationships. Data gathered from Spanish international new ventures and international mature firms show that marketing and technological ties significantly affect inter‐firm network management activities in international new ventures, while reputational ties only have effects in the case of international mature firms. Inter‐firm network management activities have a positive effect on performance in both samples. This paper provides evidence that firms' networks differ from one type of firm to another. Our findings suggest ways managers can influence networks to obtain benefits from inter‐firm network management activities. Copyright © 2017 ASAC. Published by John Wiley & Sons, Ltd.

show abstract

Vertical alliance networks: The case of university–biotechnology–pharmaceutical alliance chains

Cited by 239 publications

References 59 publications

The Role of Venture Capital on Innovation in the Korean Biotechnology Industry

The Role of Venture Capital on Innovation in the Korean Biotechnology Industry

The commercialisation of emerging energy technologies: the strategic alliances of high-technology entrepreneurial firms

Influence of network ties on inter‐firm network management activities. A comparative study between international new ventures and international mature firms

Contact Info

Product

Resources

About